Do you know what are advanced breast cancer, locally advanced breast cancer, or metastatic breast cancer in clinical trial eligibility criteria? Learn the terminologies here.
COVID-19 has led to a surge of advances in technology to provide alternative ways to get cancer care, including telemedicine, mobile apps for your phone, and artificial intelligence solutions…
ESMO Congress was held virtually September 19-21. See the latest news in metastatic breast cancer.
Metastatic Breast Cancer Awareness Day is a day selected to focus on MBC. Learn the experiences of living with MBC and ways how you can help.
Imaging tests like PET scans and MRIs are used throughout metastatic breast cancer treatment. Learn the current and future imaging tests for people with MBC.
Click to find clinical trials that have been added to BreastCancerTrials.org and Metastatic Trial Search in October 2020, including trials for TNBC, HR positive and HER2 positive breast cancer, and others.
Learn about how metastatic breast cancer can impact your job, steps you can take to prepare for tough conversations, and resources for support.
We have collected trusted information about COVID-19 that is especially relevant to people with breast cancer. This page will be updated regularly during the pandemic.
To qualify for Tecentriq®-based immunotherapy, the cancer must test positive for the PD-L1 protein. Learn what researchers have found about PD-L1 and other biomarkers to identify patients suited for immunotherapy.
The idea of finding and entering a clinical trial can seem daunting. Here’s a Clinical Trials Primer to get you started.
for past articles or specific information.